Markert E - Search Results

1

Markert E, Gruber-Moesenbacher U, Porubsky C, Popper HH. Markert E, et al. Virchows Arch. 2006 Jul;449(1):117-20. doi: 10.1007/s00428-006-0205-6. Epub 2006 Apr 26. Virchows Arch. 2006. PMID: 16639606

2

Enhanced proliferation and decreased apoptosis in lung lavage cells of sarcoidosis patients.

Petzmann S, Maercker C, Markert E, Kern I, Osolnik K, Pohl W, Popper HH. Petzmann S, et al. Among authors: markert e. Sarcoidosis Vasc Diffuse Lung Dis. 2006 Oct;23(3):190-200. Sarcoidosis Vasc Diffuse Lung Dis. 2006. PMID: 18038918

3

FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.

Amary F, Markert E, Berisha F, Ye H, Gerrand C, Cool P, Tirabosco R, Lindsay D, Pillay N, O'Donnell P, Baumhoer D, Flanagan AM. Amary F, et al. Among authors: markert e. Am J Surg Pathol. 2019 Dec;43(12):1661-1667. doi: 10.1097/PAS.0000000000001355. Am J Surg Pathol. 2019. PMID: 31490237

4

High diagnostic value of morphologic examination and molecular analysis of bone marrow biopsies in a case of BCR-ABL+ CML with clusters of blasts.

Markert E, Siebolts U, Odenthal M, Kreuzer KA, Wickenhauser C. Markert E, et al. Int J Hematol. 2009 Apr;89(3):294-297. doi: 10.1007/s12185-009-0257-x. Epub 2009 Feb 20. Int J Hematol. 2009. PMID: 19229589

5

Evolution of PTLD following renal transplantation in a child.

Markert E, Siebolts U, Habbig S, Odenthal M, Dienes HP, Stippel DL, Hoppe B, Wickenhauser C. Markert E, et al. Pediatr Transplant. 2009 May;13(3):379-83. doi: 10.1111/j.1399-3046.2008.00988.x. Epub 2008 Oct 7. Pediatr Transplant. 2009. PMID: 19017284

6

Benchmarking of mutation diagnostics in clinical lung cancer specimens.

Querings S, Altmüller J, Ansén S, Zander T, Seidel D, Gabler F, Peifer M, Markert E, Stemshorn K, Timmermann B, Saal B, Klose S, Ernestus K, Scheffler M, Engel-Riedel W, Stoelben E, Brambilla E, Wolf J, Nürnberg P, Thomas RK. Querings S, et al. Among authors: markert e. PLoS One. 2011 May 5;6(5):e19601. doi: 10.1371/journal.pone.0019601. PLoS One. 2011. PMID: 21573178 Free PMC article.

7

Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitors.

Ansén S, Bangard C, Querings S, Gabler F, Scheffler M, Seidel D, Saal B, Zander T, Nogová L, Töpelt K, Markert E, Stoelben E, Ernestus K, Thomas RK, Wolf J. Ansén S, et al. Among authors: markert e. J Thorac Oncol. 2010 Mar;5(3):407-9. doi: 10.1097/JTO.0b013e3181cf32aa. J Thorac Oncol. 2010. PMID: 20186030 Free article. No abstract available.

8

Improving the efficacy of targeted trials by multiple-marker analysis in castration-resistant prostate cancer.

Ohlmann CH, Markert E, Gerharz M, Dienes HP, Stöckle M, Engelmann U, Heidenreich A. Ohlmann CH, et al. Among authors: markert e. Urol Oncol. 2011 Nov-Dec;29(6):664-9. doi: 10.1016/j.urolonc.2009.09.010. Epub 2009 Nov 26. Urol Oncol. 2011. PMID: 19942459

9

[Feasibility of targeted therapy based on immunohistochemical expression analysis in androgen-independent prostate cancer].

Ohlmann CH, Markert E, Gerharz M, Pfister D, Dienes HP, Engelmann U, Heidenreich A. Ohlmann CH, et al. Among authors: markert e. Urologe A. 2008 Sep;47(9):1218-23. doi: 10.1007/s00120-008-1839-6. Urologe A. 2008. PMID: 18679646 German.

10

Spindle cell/pleomorphic lipoma of the seminal vesicle: First description of a rare benign mesenchymal tumor.

Lyatoshinsky P, Pratsinis M, Markert E, Schmid HP, Müllhaupt G. Lyatoshinsky P, et al. Among authors: markert e. Urol Case Rep. 2023 Jan 30;47:102337. doi: 10.1016/j.eucr.2023.102337. eCollection 2023 Mar. Urol Case Rep. 2023. PMID: 36816611 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page